- Forums
- ASX - By Stock
- ALL
- ALL - 'ALL in ' Why ALL is a defensive against
ALL - 'ALL in ' Why ALL is a defensive against, page-53
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALL (ASX) to my watchlist
|
|||||
Last
$52.31 |
Change
-1.350(2.52%) |
Mkt cap ! $33.27B |
Open | High | Low | Value | Volume |
$53.49 | $53.50 | $52.30 | $23.45M | 444.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 537 | $52.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$52.33 | 128 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 433 | 52.500 |
9 | 1397 | 52.490 |
6 | 157 | 52.480 |
2 | 81 | 52.470 |
2 | 84 | 52.460 |
Price($) | Vol. | No. |
---|---|---|
52.520 | 561 | 7 |
52.530 | 406 | 8 |
52.540 | 399 | 8 |
52.550 | 125 | 5 |
52.560 | 367 | 9 |
Last trade - 11.44am 16/07/2024 (20 minute delay) ? |
Featured News
ALL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online